Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

8876

1

GlucoTrack, Inc. GlucoTrack Reports Significant Financial Challenges, Net Losses, and Doubt About Future Operations

Via official filing (AI summary) | 6 months ago | 0 comments

8877

1

MILESTONE SCIENTIFIC INC. Milestone Scientific Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8878

1

Estrella Immunopharma, Inc. Estrella Immunopharma Reports Significant Financial Decline, Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

8879

1

AVENUE THERAPEUTICS, INC. Avenue Therapeutics Reports Net Loss and Increased Research Expenses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8880

1

Horizon Space Acquisition I Corp. Horizon Space Acquisition I Corp. Reports Net Income Decline, Liquidity Concerns in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

8881

1

Envirotech Vehicles, Inc. Envirotech Vehicles Reports Significant Decline in Revenue and Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8882

1

Constellation Acquisition Corp I Constellation Acquisition Corp I Reports Improved Financial Performance, Reduced Losses, and Strategic Developments

Via official filing (AI summary) | 6 months ago | 0 comments

8883

1

AYRO, Inc. Ayro Inc. Reports Significant Financial Changes in 10-Q Filing, Despite Revenue Decline

Via official filing (AI summary) | 6 months ago | 0 comments

8884

1

GT Biopharma, Inc. GT Biopharma Reports Mixed Financial Results, Net Loss, and Ongoing Challenges in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8885

1

GLOBAL ACQUISITIONS Corp Global Acquisitions Corporation Reports Mixed Financial Results in Q3 2024, Secures Additional Funding

Via official filing (AI summary) | 6 months ago | 0 comments

8886

1

Binah Capital Group, Inc. Binah Capital Reports Mixed Q3 Results, Net Loss, and Increased Assets Following Reverse Recapitalization

Via official filing (AI summary) | 6 months ago | 0 comments

8887

1

N2OFF, Inc. N2OFF, Inc. Reports Significant Financial Challenges, Decline in Revenues and Gross Loss

Via official filing (AI summary) | 6 months ago | 0 comments

8888

1

Agrify Corp Agrify Corporation Reports 38% Revenue Decline, Reduces Costs and Debt in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

8889

1

ECA Marcellus Trust I ECA Marcellus Trust I Reports Decreased Assets, Revenue, and Distributions Amid Market Volatility

Via official filing (AI summary) | 6 months ago | 0 comments

8890

1

KIDPIK CORP. Kidpik Corp. Reports Significant Financial Challenges, Decline in Revenue and Net Loss in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

8891

1

Vivos Therapeutics, Inc. Vivos Therapeutics Reports 17% Revenue Growth, Improved Operational Efficiency, and Strategic Developments in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8892

1

WinVest Acquisition Corp. WinVest Acquisition Corp. Reports Significant Financial Changes, Raises Doubts Over Going Concern

Via official filing (AI summary) | 6 months ago | 0 comments

8893

1

Data443 Risk Mitigation, Inc. Data443 Risk Mitigation Reports 65% Revenue Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

8894

1

Lineage Cell Therapeutics, Inc. Lineage Cell Therapeutics Reports 203% Revenue Growth, Improved Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8895

1

Sidus Space Inc. Sidus Space Reports 90% Revenue Growth, Narrowing Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8896

1

InMed Pharmaceuticals Inc. InMed Pharmaceuticals Reports 40% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8897

1

Ascent Solar Technologies, Inc. Ascent Solar Technologies Reports Significant Financial Improvements Amid Revenue Decline

Via official filing (AI summary) | 6 months ago | 0 comments

8898

1

GAXOS.AI INC. Gaxos.ai Reports Revenue Growth, Improved Net Loss, and Strategic Initiatives in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8899

1

OMNIQ Corp. OMNIQ Corp. Reports Mixed Q3 2024 Results, Net Loss Improvement, and Strategic Acquisitions and Divestitures

Via official filing (AI summary) | 6 months ago | 0 comments

8900

1

Graf Global Corp. Graf Global Corp. Reports Financial Results Following IPO, Net Income of $2.8 Million for Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments